Laurence P. Diggs, MD
Department of Surgical Oncology, Division of Surgery
Present Title & Affiliation
Primary Appointment
Assistant Professor, Surgical Oncology, Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas
Fellow, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2015 | St Georges University School of Medicine, St. George, GD, MD |
| 2007 | McGill University, Montreal, QC, CA, Economic, BA |
Postgraduate Training
| 2024-2025 | Research Fellow, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2023-2026 | Fellow, Complex General Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2020-2023 | Resident, General Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey |
| 2017-2020 | Postgraduate Research Fellow, National Cancer Institute, Bethesda, Maryland |
| 2015-2017 | Resident, General surgery, St. Louis University School of Medicine, St. Louis, Missouri |
Licenses & Certifications
| 2024 | American Board of Surgery |
| 2023 | Laurence Diggs UTMB Medical license |
Experience & Service
Administrative Appointments/Responsibilities
Member of quality improvement for medical student education committee, Surgery, Saint Louis University School of Medicine, Saint Louis, Missouri, 2020 - 2017
Junior Surgeon, Crossing for Mercy Surgical Mission, Yendi General Hospital, 2019 - 2019
House surgical consultant, Surgery, Johns Hopkins Medicine, Washington, D.C, District of Columbia, 2018 - 2020
Author: handbook for third year medical school general surgery clerkship, Surgery, Saint Louis University School of Medicine, Saint Louis, Missouri, 2016
Class Representative, SGU Student Government Association, St. George University, West Indies, 2011 - 2015
VP of the St-George’s University Surgery Club, St. George's University-SOM Northumbria, Newcastle, 2011 - 2011
Other Professional Positions
Education & Academic Affairs Fellow, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - 2026
Surgery Advisor to Junior Residents for Research and Scholarly Activities, Rutgers Robert Wood Johnson SOM Department of Surgery, New Brunswick, New Jersey, 2022 - 2023
Surgery Advisor to Junior Residents for Research and Scholarly Activities, Rutgers Robert Wood Johnson SOM Dept. of Surgery, New Brunswick, New Jersey, 2021 - 2022
President of Journal Club, NCI, NIH, Bethesda, Maryland, 2017 - 2019
President of General Surgery Journal Club, Saint Louis School of Medicine, St. Louis, Missouri, 2016 - 2017
Honors & Awards
| 2026 - Present | Lotzova Memoriral Basic Science/Translational Research Award - at that 2026 Fellows Graduation Ceremony, The University of Texas MD Anderson Cancer Center |
| 2023 - Present | First Place Prize, Department of Surgery Clinical Trials Course, The University of Texas MD Anderson Cancer Center |
| 2023 - Present | Lowry Award for Outstanding Contribution to the Residency, Rutgers Universiity School of Medicine |
| 2022 - Present | Resident of the Season, Rutgers University School of Medicine |
| 2022 - Present | AOA Medical Honors Society Induction as Resident, Rutgers University School of Medicine |
| 2022 - Present | Commendation for exceptional care, Rutgers University School of Medicine |
| 2022 - Present | DEAK Award for Excellence in Research, Rutgers University School of Medicine |
| 2021 - Present | Resident of the month, New Jersey ACS Chapter |
| 2021 - Present | Award for best basic science research contribution, Rutgers University SOM Dept. of Surgery |
| 2021 - Present | Resident Research Day Award for contribution to finding a cure for cholangiocarcinoma, Cholangiocarcinoma Foundation Annual Meeting |
| 2021 - Present | Poster Award 2nd place, Princeston Medical Center |
| 2020 - Present | National Cancer Institute’s Academic Productivity Award, Surgical Oncology Program |
| 2020 - Present | Presidential address session podium presentation, AHPBA Annual Meeting |
| 2020 - Present | National Cancer Institute’s Surgeon Scientist Award, Surgical Oncology Program |
| 2016 - Present | Distinction awarded to a resident for teaching, Saint Louis University School of Medicine |
| 2016 - Present | “SSMile” award for exceptional patient care, SSM Cardinal Glennon Children’s Hospital |
| 2012 - Present | IEA International Medical Honors Society, St-George’s University |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2021. Modulating Cholangiocarcinoma’s Hostile Tumor Microenvironment Using a CD40 agonist Improves Response to Immune Checkpoint Blockade. Conference. Newark, New Jersey.
- 2021. Improving surgical cost effectiveness through cost awareness and guideline education. Invited. Piscataway, New Jersey, US.
National Presentations
- 2025. Imaging Mass Cytometry (IMC) Reveals Distinct Differences in Intratumoral B and T Regulatory Cell Populations in Responder versus Non-Responder Soft Tissue Sarcoma (STS) Patients Before Treatment with Immune Checkpoint Blockade (ICB). Poster. Chicago, Illinois, US.
- 2025. Optimizing Preoperative Evaluations for Patients with Colorectal Cancer with Peritoneal Metastases. Poster. Scottsdale, Arizona, US.
- 2024. Use of Air Leak Test to Reduce Bile Leak & Organ Space Infection: A Step Towards More Drain-Free Hepatectomy Patients. Invited. Washington, DC, US.
- 2024. Prospective Evaluation of Provider Compliance with Risk- Stratified Pancreatectomy Clinical Pathways. Invited. Washington, DC, US.
- 2023. The surgeon-scientist: bridging the gap between the OR and the bedside. Invited. Seminar for Research Students.
- 2022. Pneumatosis intestinalis: to treat or not to treat. Poster, US.
- 2022. Intrahepatic Cholangiocarcinoma: How Do Hepatectomy Outcomes Compare to Liver Metastases and Hepatocellular Carcinoma? (e-Poster). Poster. New York, New York, US.
- 2021. From Bench to the Operating Room and Back Again: Bridging the Gap Between Science and Surgery. OnlineOnly, US.
- 2021. Modulating Cholangiocarcinoma’s Hostile Tumor Microenvironment Using a CD40 agonist Improves Response to Immune Checkpoint Blockade. OnlineOnly.
- 2020. The role of platelets in anti-tumor immune surveillance in NASH. OnlineOnly.
- 2020. Modulating Cholangiocarcinoma’s Hostile Tumor Microenvironment Using a CD40 agonist Improves Response to Immune Checkpoint Blockade. Invited. Miami, Florida, US.
- 2019. Modulating Cholangiocarcinoma’s Hostile Tumor Microenvironment Using a CD40 agonist Improves Response to Immune Checkpoint Blockade. Invited. Bethesda, Maryland, US.
- 2019. Mcl-1 Contributes to ‘Minority MOMP’ involved in Bile Acid-Induced Esophageal Carcinogenesis. Invited. Toronto, Ontario, CA.
- 2019. Patient factors contributing to disparate perioperative outcomes following major hepatic resection. Invited. Miami, Florida, US.
- 2016. HIPEC as Bridge to Chemotherapy. Invited. Lake of the Ozarks, Missouri, US.
- 2016. Technique for laparoscopic HIPEC. Invited. Lake of the Ozarks, Missouri, US.
- 2015. Bariatric Surgical Procedures Safe in the Super-Obese. Poster. Nashville, Tennessee, US.
- 2015. Surgical Aspiration as an Alternative to Colonic Resection for Selected Cases of Acute Diverticulitis. Poster. Nashville, Tennessee, US.
- 2014. Rib Fractures In The Elderly: A Comparison Of Imaging Modalities. Poster. New York City, New York, US.
Selected Publications
Peer-Reviewed Articles
- Chang M, Wang Y, Ha J, Neale ZR, Ajami NJ, Diggs LP, Nalin AP, Ma Y, Dong S, Hoballah YM, Day A, Jeong SD, Wu A, Schrank BR, Edwards JL, Wang T, Wang X, Chang YT, Tang C, Lim AJ, Torres MN, Deng W, Peitsch T, Dufilho MJ 4th, Goswami S, Jiang D, Koong AC, Sharma P, Wargo JA, Jiang W, Kim BYS. A transferable gut microbiota-bile acid pathway programs nanomedicine pharmacokinetics and therapeutic response. Nat Mater 25(9):1634-1645, 2026. e-Pub 2026. PMID: 42538384.
- Lobel L, Fonseca-Pereira D, Nakatsu G, Michaud M, Cao YG, Bae S, Krabak C, Oren Y, Clay SL, El Tekle G, Chun E, Kon S, Chan AT, Clardy J, Glickman JN, Ajami NJ, Day A, Damania A, Baruch EN, White MG, Diggs LP, Wargo J, Riffelmacher T, Balancio A, Kronenberg M, Huttenhower C, Garrett WS. Dietary sulfur amino acids enhance anti-tumor immunity in colon cancer via an NKT cell-XCL1-cDC1 circuit. Immunity 59(6):1708-1725.e12, 2026. e-Pub 2026. PMID: 42190649.
- Ayabe RI, Seo YD, Melendez B, Fields BC, Diggs LP, Lazcano R, Singh BB, Wani K, Ingram D, Johnson S, Chelvanambi M, Hudgens C, Hernandez SD, Ajami NJ, Wargo JA, Lazar AJ, Knafl M, Woodman S, Halperin DM, Estrella JS, Maxwell JE. Cancer Testis Antigen Expression Correlates With Immune Activation and Survival in Small Bowel Neuroendocrine Tumors. JCO Precis Oncol 9:e2500107, 2025. e-Pub 2025. PMID: 40638874.
- In H, Perati SR, Usyk M, Yang J, Sarkar S, Rana B, Wang F, Oh A, Adams A, Diggs LP, Sollecito C, Burk RD. Oral Microbiome Signatures as Potential Biomarkers for Gastric Cancer Risk Assessment. J Gastrointest Surg:101933, 2024. e-Pub 2024. PMID: 39706288.
- Green BL, Gamble LA, Diggs LP, Nousome D, Patterson JC, Joughin BA, Gasmi B, Lux SC, Samaranayake SG, Miettinen M, Quezado M, Hernandez JM, Yaffe MB, Davis JL. Early Immune Changes Support Signet Ring Cell Dormancy in CDH1-Driven Hereditary Diffuse Gastric Carcinogenesis. Mol Cancer Res 21(12):1356-1365, 2023. e-Pub 2023. PMID: 37707375.
- Pepe, R, Diggs, LP, Foley, FW, Moore, T, Williams, DA, Patel, NM. Leadership Coaching in Surgical Residency. Journal of Surgical Education 80(11):1529-1535, 2023. e-Pub 2023. PMID: 37479647.
- Diggs LP, Fagenson AM, Putatunda V, Lau KN, Grandhi MS, Pitt HA. Intrahepatic cholangiocarcinoma: how do hepatectomy outcomes compare to liver metastases and hepatocellular carcinoma?. HPB (Oxford) 25(11):1420-1428, 2023. e-Pub 2023. PMID: 37573232.
- Ma C, Fu Q, Diggs LP, McVey JC, McCallen J, Wabitsch S, Ruf B, Brown Z, Heinrich B, Zhang Q, Rosato U, Wang S, Cui L, Berzofsky JA, Kleiner DE, Bosco DB, Wu LJ, Lai CW, Rotman Y, Xie C, Korangy F, Greten TF. Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD. Cancer Cell 40(9):986-998.e5, 2022. e-Pub 2022. PMID: 36055226.
- Wabitsch S, McCallen JD, Kamenyeva O, Ruf B, McVey JC, Kabat J, Walz JS, Rotman Y, Bauer KC, Craig AJ, Pouzolles M, Phadke I, Catania V, Green BL, Fu C, Diggs LP, Heinrich B, Wang XW, Ma C, Greten TF. Metformin treatment rescues CD8(+) T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD. J Hepatol 77(3):748-760, 2022. e-Pub 2022. PMID: 35378172.
- Heinrich B, Gertz EM, Schaffer AA, Craig A, Ruf B, Subramanyam V, McVey JC, Diggs LP, Heinrich S, Rosato U, Ma C, Yan C, Hu Y, Zhao Y, Shen TW, Kapoor V, Telford W, Kleiner DE, Stovroff MK, Dhani HS, Kang J, Fishbein T, Wang XW, Ruppin E, Kroemer A, Greten TF, Korangy F. The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma. Gut 71(6):1161-1175, 2022. e-Pub 2022. PMID: 34340996.
- McVey JC, Green BL, Ruf B, McCallen JD, Wabitsch S, Subramanyam V, Diggs LP, Heinrich B, Greten TF, Ma C. NAFLD indirectly impairs antigen-specific CD8(+) T cell immunity against liver cancer in mice. iScience 25(2):103847, 2022. e-Pub 2022. PMID: 35198900.
- Drake JA, Diggs LP, Martin SP, Wach MM, Jafferji MS, Steinberg SM, Blakely AM, Davis JL, Hoang CD, Ripley RT, Hernandez JM. Characteristics of Matriculants to Thoracic Surgery Residency Training Programs. Ann Thorac Surg 112(6):2070-2075, 2021. e-Pub 2021. PMID: 33378696.
- Ruf B, Catania VV, Wabitsch S, Ma C, Diggs LP, Zhang Q, Heinrich B, Subramanyam V, Cui LL, Pouzolles M, Evans CN, Chari R, Sakai S, Oh S, Barry CE 3rd, Barber DL, Greten TF. Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response. Cancer Immunol Res 9(9):1024-1034, 2021. e-Pub 2021. PMID: 34193462.
- Surman DR, Xu Y, Lee MJ, Trepel J, Brown K, Ramineni M, Splawn TG, Diggs LP, Hodges HC, Davis JL, Lee HS, Burt BM, Ripley RT. Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling. Mol Cancer Ther 20(8):1469-1480, 2021. e-Pub 2021. PMID: 34088830.
- Torres MB, Diggs LP, Wei JS, Khan J, Miettinen M, Fasaye GA, Gillespie A, Widemann BC, Kaplan RN, Davis JL, Hernandez JM, Rivero JD. Ataxia telangiectasia mutated germline pathogenic variant in adrenocortical carcinoma. Cancer Genet 256-257:21-25, 2021. e-Pub 2021. PMID: 33836455.
- Diggs LP, Aversa JG, Wiemken TL, Martin SP, Drake JA, Ruff SM, Wach MM, Brown ZJ, Blakely AM, Davis JL, Luu C, Hernandez JM. Patient Comorbidities Drive High Mortality Rates Associated with Major Liver Resections Irrespective of Hospital Volume. Am Surg 87(7):1163-1170, 2021. e-Pub 2021. PMID: 33345554.
- Diggs LP, Ruf B, Ma C, Heinrich B, Cui L, Zhang Q, McVey JC, Wabitsch S, Heinrich S, Rosato U, Lai W, Subramanyam V, Longerich T, Loosen SH, Luedde T, Neumann UP, Desar S, Kleiner D, Gores G, Wang XW, Greten TF. CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma. J Hepatol 74(5):1145-1154, 2021. e-Pub 2021. PMID: 33276030.
- Zhang Q, Ma C, Duan Y, Heinrich B, Rosato U, Diggs LP, Ma L, Roy S, Fu Q, Brown ZJ, Wabitsch S, Thovarai V, Fu J, Feng D, Ruf B, Cui LL, Subramanyam V, Frank KM, Wang S, Kleiner DE, Ritz T, Rupp C, Gao B, Longerich T, Kroemer A, Wang XW, Ruchirawat M, Korangy F, Schnabl B, Trinchieri G, Greten TF. Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma. Cancer Discov 11(5):1248-1267, 2021. e-Pub 2021. PMID: 33323397.
- Diggs LP, Martin SP, Drake JA, Ripley RT. Video-assisted thoracoscopic surgery pleurectomy: a suitable alternative for treating malignant pleural effusions. J Thorac Dis 13(4):2177-2183, 2021. e-Pub 2021. PMID: 34012568.
- Hung MH, Lee JS, Ma C, Diggs LP, Heinrich S, Chang CW, Ma L, Forgues M, Budhu A, Chaisaingmongkol J, Ruchirawat M, Ruppin E, Greten TF, Wang XW. Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma. Nat Commun 12(1):1455, 2021. e-Pub 2021. PMID: 33674593.
- Aversa JG, Diggs LP, Hagerty BL, Dominguez DA, Ituarte PHG, Hernandez JM, Davis JL, Blakely AM. Multivisceral Resection for Locally Advanced Gastric Cancer. J Gastrointest Surg 25(3):609-622, 2021. e-Pub 2021. PMID: 32705611.
- Wabitsch S, McVey JC, Ma C, Ruf B, Kamenyeva O, McCallen JD, Diggs LP, Heinrich B, Greten TF. Hydroxychloroquine can impair tumor response to anti-PD1 in subcutaneous mouse models. iScience 24(1):101990, 2021. e-Pub 2021. PMID: 33490900.
- Heinrich B, Brown ZJ, Diggs LP, Vormehr M, Ma C, Subramanyam V, Rosato U, Ruf B, Walz JS, McVey JC, Wabitsch S, Fu Q, Yu SJ, Zhang Q, Lai CW, Sahin U, Greten TF. Steatohepatitis Impairs T-cell-Directed Immunotherapies Against Liver Tumors in Mice. Gastroenterology 160(1):331-345.e6, 2021. e-Pub 2021. PMID: 33010248.
- Wabitsch S, Tandon M, Ruf B, Zhang Q, McCallen JD, McVey JC, Ma C, Green BL, Diggs LP, Heinrich B, Greten TF. Anti-PD-1 in Combination With Trametinib Suppresses Tumor Growth and Improves Survival of Intrahepatic Cholangiocarcinoma in Mice. Cell Mol Gastroenterol Hepatol 12(3):1166-1178, 2021. e-Pub 2021. PMID: 34033968.
- Dominguez DA, Aversa JG, Hagerty BL, Diggs LP, Raoof M, Davis JL, Hernandez JM, Blakely AM. Prognostic impact of lymphovascular invasion in pT1-T3 gallbladder adenocarcinoma. J Surg Oncol 122(7):1401-1408, 2020. e-Pub 2020. PMID: 32783204.
- Hagerty BL, Aversa J, Diggs LP, Dominguez DA, Ayabe RI, Blakely AM, Davis JL, Luu C, Hernandez JM. Characterization of alveolar soft part sarcoma using a large national database. Surgery 168(5):825-830, 2020. e-Pub 2020. PMID: 32703677.
- Ayabe RI, Wach MM, Ruff SM, Diggs LP, Martin SP, Wiemken T, Hinyard L, Davis JL, Luu C, Hernandez JM. Gallbladder squamous cell carcinoma: An analysis of 1084 cases from the National Cancer Database. J Surg Oncol 122(4):716-722, 2020. e-Pub 2020. PMID: 32510655.
- Aversa JG, Diggs LP, Hagerty BL, Dominguez DA, Wiemken T, Luu C, Hernandez JM. Trends of Clinician Adherence to Evidence-Based Recommendations for Multidisciplinary Oncology Care for Patients With Esophageal Cancer. JAMA Oncol 6(8):1290-1292, 2020. e-Pub 2020. PMID: 32437494.
- Ruff SM, Rothermel LD, Diggs LP, Wach MM, Ayabe RI, Martin SP, Boulware D, Anaya D, Davis JL, Mullinax JE, Hernandez JM. Tumor grade may be used to select patients with multifocal hepatocellular carcinoma for resection. HPB (Oxford) 22(7):1004-1010, 2020. e-Pub 2020. PMID: 31734237.
- Martin SP, Drake J, Wach MM, Ruff SM, Diggs LP, Wan JY, Good ML, Dominguez DA, Ayabe RI, Glazer ES, Dickson PV, Davis JL, Deneve JL, Hernandez JM. Resection and chemotherapy is the optimal treatment approach for patients with clinically node positive intrahepatic cholangiocarcinoma. HPB (Oxford) 22(1):129-135, 2020. e-Pub 2020. PMID: 31326265.
- Diggs LP, Greten TF. The effects of platelet accumulation in fatty liver disease. Nat Rev Gastroenterol Hepatol 16(7):393-394, 2019. e-Pub 2019. PMID: 31114057.
- Ruff SM, Ayabe RI, Wach MM, Diggs LP, Martin SP, Davis JL, Hernandez JM. Practice patterns of VTE chemoprophylaxis after discharge following hepatic and pancreatic resections for cancer: A survey of hepatopancreatobiliary surgeons. J Thromb Thrombolysis 48(1):119-124, 2019. e-Pub 2019. PMID: 30877618.
- Martin SP, Drake J, Wach MM, Ruff S, Diggs LP, Wan JY, Brown ZJ, Ayabe RI, Glazer ES, Dickson PV, Davis JL, Deneve JL, Hernandez JM. Laparoscopic Approach to Intrahepatic Cholangiocarcinoma is Associated with an Exacerbation of Inadequate Nodal Staging. Ann Surg Oncol 26(6):1851-1857, 2019. e-Pub 2019. PMID: 30895496.
- Martin SP, Ruff S, Diggs LP, Drake J, Ayabe RI, Brown ZJ, Wach MM, Steinberg SM, Davis JL, Hernandez JM. Tumor grade and sex should influence the utilization of portal lymphadenectomy for early stage intrahepatic cholangiocarcinoma. HPB (Oxford) 21(4):419-424, 2019. e-Pub 2019. PMID: 30139566.
- Diggs LP, Lobb J, Tu C, Osborn T, Wade TP. Necrotizing Soft Tissue Infection of the Right Lower Extremity after Ingestion of a Foreign Body. Am Surg 84(12):e508-e509, 2018. e-Pub 2018. PMID: 30606358.
- Wach MM, Ruff SM, Ayabe RI, Martin SP, Diggs LP, Alexander IA, Steinberg SM, Davis JL, Hernandez JM. An Examination of Applicants and Factors Associated with Matriculation to Complex General Surgical Oncology Fellowship Training Programs. Ann Surg Oncol 25(12):3436-3442, 2018. e-Pub 2018. PMID: 30054823.
- Feingold PL, Surman DR, Brown K, Xu Y, McDuffie LA, Shukla V, Reardon ES, Crooks DR, Trepel JB, Lee S, Lee MJ, Gao S, Xi S, McLoughlin KC, Diggs LP, Beer DG, Nancarrow DJ, Neckers LM, Davis JL, Hoang CD, Hernandez JM, Schrump DS, Ripley RT. Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma. Mol Cancer Ther 17(9):2013-2023, 2018. e-Pub 2018. PMID: 29934340.
- Taylor Ripley R, Surman DR, Diggs LP, Trepel JB, Lee MJ, Ryan J, Davis JL, Steinberg SM, Hernandez JM, Hoang C, Kenney CM, Bond CD, Kunst TF, Letai A, Schrump DS. Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy. BMC Gastroenterol 18(1):94, 2018. e-Pub 2018. PMID: 29933761.
Review Articles
- Lewis KA, Diggs LP, Badgwell BD. Educational Review: Updates on Therapeutic Strategies for Gastric Cancer with Peritoneal Metastasis. Ann Surg Oncol 32(5):3672-3687, 2025. e-Pub 2025. PMID: 40016614.
- Diggs LP, Gregory S, Choron RL. Review of Traumatic Duodenal Injuries: Etiology, Diagnosis, and Management. Am Surg 89(5):1989-1996, 2023. e-Pub 2023. PMID: 34974741.
- Diggs LP, Hsueh EC. Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response. Biomark Res 5:12, 2017. e-Pub 2017. PMID: 28331612.
Other Articles
- Diggs L. PMID: 30807846.
Editorials
- Diggs LP, Newhook TE. Better Outcomes by Measuring Function? Predicting Functional Future Liver Remnant Using Tc-GSA SPECT/CT in Perihilar Cholangiocarcinoma. Ann Surg Oncol 32(9):6201-6202, 2025. PMID: 40389666.
- Diggs LP, Ripley RT. Da Vinci's ascent: Continually broadening the scope of robotic thoracic surgery. J Thorac Cardiovasc Surg 156(2):e133-e134, 2018. PMID: 29555087.
- Diggs LP, Ripley RT. The good, the bad, and the uncertain: Can matrix metalloproteinase 12 simultaneously be protumorigenic and antitumorigenic?. J Thorac Cardiovasc Surg 155(5):2162-2163, 2018. PMID: 29397150.
- Keller J, Diggs LP, Hsueh EC. Prognostic molecular testing in melanoma: ready for prime time?. Melanoma Manag 4(4):171-174, 2017. PMID: 30190922.
Book Chapters
- Diggs, LP, Grandhi, MS. Management of Gastrointestinal Stromal Tumors, 111-119, 2023.
- Diggs LP, Tran Cao HS. Surgical Management of Gallbladder cancer Diagnosed Intra-operatively. In: Gallbladder Cancer - A Comprehensive Guide To Management. 1st. Springer.
- Diggs LP, Grandhi MS. Surgical Management of Gastrointestinal Stromal Tumors. In: Current Surgical Therapy. 14th.
- Diggs LP, Greten TF. Immunotherapy for Hepatocellular Carcinoma. In: Cancer Immunotherapy Principles and Practice. McGraw-Hill.
Patient Reviews
CV information above last modified September 15, 2026